Mubadala Capital Investments

Mubadala Capital has invested in 8 companies and its latest investment was Tenvie Therapeutics on Jan 07, 2025

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

$200M
Jan 07, 2025
-
Auron is a Massachusetts-based biotechnology company that develops and commercializes therapies for the treatment of cancer.
$27M
Dec 17, 2024
-
Silver Rock Financial offers asset management, investment strategies, financial planning and advisory services.
-
Dec 04, 2024
-
Outpace Bio is a Washington-based biotechnology company that researches and develops T-cell therapies to treat cancer.
$144M
Jul 31, 2024
-
Iambic is a California-based AI-driven drug discovery platform that provides molecular design and development solutions for the healthcare industry.
$50M
Apr 14, 2024
-

Frequently Asked Questions about Mubadala Capital

  1. What is Mubadala Capital investing in?

    Mubadala Capital has invested in 8 companies including Tenvie Therapeutics, Auron and Silver Rock Financial
  2. What company did Mubadala Capital invest in?

    Mubadala Capital invested in a total 8 companies including Tenvie Therapeutics, Auron and Silver Rock Financial
  1. What are the top 5 investments by Mubadala Capital?

    The top companies in which Mubadala Capital invested are Tenvie Therapeutics, Auron, Silver Rock Financial, Outpace and Iambic